BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA
457 results:

  • 1. Appraisal of folate functionalized bosutinib cubosomes against hepatic cancer cells: In-vitro, In-silico, and in-vivo pharmacokinetic study.
    Nisha R; Kumar P; Mishra N; Maurya P; Ahmad S; Singh N; Saraf SA
    Int J Pharm; 2024 Apr; 654():123975. PubMed ID: 38452833
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Sorafenib and tetrakis (4-carboxyphenyl) porphyrin assembled nanoparticles for synergistic targeted chemotherapy and sonodynamic therapy of hepatocellular carcinoma.
    Chen Y; Tan Q; Tang Y; Pang E; Peng R; Lan M; Bai D
    Biomater Sci; 2024 Mar; 12(7):1864-1870. PubMed ID: 38411494
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review).
    Wang J; Li J; Fu Y; Zhu Y; Lin L; Li Y
    Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38362962
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Synthesis and Characterization of Graphene Oxide/Polyethylene Glycol/Folic Acid/Brucine Nanocomposites and Their Anticancer Activity on HepG2 Cells.
    Ibrahim IAA; Alzahrani AR; Alanazi IM; Shahzad N; Shahid I; Falemban AH; Nur Azlina MF; Arulselvan P
    Int J Nanomedicine; 2024; 19():1109-1124. PubMed ID: 38344441
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Systemic Neutrophil Gelatinase-Associated Lipocalin Alterations in Chronic Pancreatitis: A Multicenter, Cross-Sectional Study.
    Gumpper-Fedus K; Chasser K; Pita-Grisanti V; Torok M; Pfau T; Mace TA; Cole RM; Belury MA; Culp S; Hart PA; Krishna SG; Lara LF; Ramsey ML; Fisher W; Fogel EL; Forsmark CE; Li L; Pandol S; Park WG; Serrano J; Van Den Eeden SK; Vege SS; Yadav D; Conwell DL; Cruz-Monserrate Z;
    Clin Transl Gastroenterol; 2024 Apr; 15(4):e00686. PubMed ID: 38284831
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Fanconi Anemia Complementary Group A (fanca) Facilitates the Occurrence and Progression of liver Hepatocellular Carcinoma.
    Huang FD; Zhong YP; Sun GY; Xu QJ; Xing ZY; Chen KH; Liao LS; Dong MY
    Dig Dis Sci; 2024 Mar; 69(3):1035-1054. PubMed ID: 38282187
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Enhancing Targeted Therapy in Hepatocellular Carcinoma through a pH-Responsive Delivery System: Folic Acid-Modified Polydopamine-Paclitaxel-Loaded Poly(3-hydroxybutyrate-
    Wu M; Wang Q; Peng Y; Liang X; Lv X; Wang S; Zhong C
    Mol Pharm; 2024 Feb; 21(2):581-595. PubMed ID: 38131328
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Rational design of NIR-II molecule-engineered nanoplatform for preoperative downstaging and imaging-guided surgery of orthotopic hepatic tumor.
    Pan Q; Li K; Kang X; Li K; Cheng Z; Wang Y; Xu Y; Li L; Li N; Wu G; Yang S; Qi S; Chen G; Tan X; Zhan Y; Tang L; Zhan W; Yang Q
    J Nanobiotechnology; 2023 Dec; 21(1):489. PubMed ID: 38111035
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Oxidative Stress in Xenograft Mouse Model Exposed to Dendrimers Decorated Polydopamine Nanoparticles and Targeted Chemo- and Photothermal Therapy.
    Witkowska M; Mrówczyński R; Grześkowiak B; Miechowicz I; Florek E
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068888
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade.
    Hamed A; Ghareeb D; Mohamed TM; Hamed M; Nofal MS; Gaber M
    BMC Complement Med Ther; 2023 Oct; 23(1):384. PubMed ID: 37891562
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. pH-Responsive and Actively Targeted Metal-Organic Framework Structures for Multimodal Antitumor Therapy and Inhibition of Tumor Invasion and Metastasis.
    Jia W; Jin B; Xu W; Liu S; Mao X; Peng H; Zhang Y
    ACS Appl Mater Interfaces; 2023 Nov; 15(43):50069-50082. PubMed ID: 37871135
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA.
    Zhang S; Huang Y; Pi S; Chen H; Ye F; Wu C; Li L; Ye Q; Lin Y; Su Z
    J Nanobiotechnology; 2023 Oct; 21(1):360. PubMed ID: 37789342
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Hepatic adenoma in a 7-year-old girl: a case report and literature review.
    Gao Y; Zhou J; Xie YC; Qiu LJ; Duan L; A ZX; Wu HF; Lv MX
    BMC Pediatr; 2023 Aug; 23(1):420. PubMed ID: 37620840
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Feeding artery: a valuable feature for differentiation of regenerative nodule, dysplastic nodules and small hepatocellular carcinoma in CEUS LI-RADS.
    Wu J; Zhao Q; Wang Y; Xiao F; Cai W; Liu S; Du Z; Yu X; Liu F; Yu J; Liang P
    Eur Radiol; 2024 Feb; 34(2):745-754. PubMed ID: 37589899
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparison Between Radial and Femoral Artery Access for Transarterial Chemoembolisation in Patients With Hepatocellular Carcinoma.
    Hedjoudje M; Barat M; Dohan A; Lucas A; Dautry R; Coriat R; Marchese U; Pol S; Parlati L; Soyer P
    Can Assoc Radiol J; 2024 Feb; 75(1):178-186. PubMed ID: 37563785
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Disturbed lipid profile in common variable immunodeficiency - a pathogenic loop of inflammation and metabolic disturbances.
    Jorgensen SF; Macpherson ME; Skarpengland T; Berge RK; Fevang B; Halvorsen B; Aukrust P
    Front Immunol; 2023; 14():1199727. PubMed ID: 37545531
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Functionalized ZnMnFe
    Liu J; Shi X; Qu Y; Wang G
    Nanoscale; 2023 Jul; 15(26):11013-11025. PubMed ID: 37341143
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Poly lactic-co-glycolic acid-alginate nanocarrier for efficient drug delivery to liver cancer cells.
    Hoseinzadeh M; Mokhtari MJ; Kafilzadeh F; Mohammadnejad J; Taheri Y
    IET Nanobiotechnol; 2023 Jul; 17(5):450-464. PubMed ID: 37309704
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Magnetic-Manipulated NK Cell Proliferation and Activation Enhance Immunotherapy of Orthotopic liver cancer.
    Jiang H; Fu H; Min T; Hu P; Shi J
    J Am Chem Soc; 2023 Jun; 145(24):13147-13160. PubMed ID: 37262421
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hepatocyte Nuclear Factor 4α (HNF4α) Plays a Controlling Role in Expression of the Retinoic Acid Receptor β (
    Zolfaghari R; Bonzo JA; Gonzalez FJ; Ross AC
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239961
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 23.